mRNA Therapeutics Market Report 2026

mRNA Therapeutics Market Overview

• mRNA Therapeutics market size has reached to $35.9 billion in 2025 • Expected to grow to $42.32 billion in 2030 at a compound annual growth rate (CAGR) of 3.3% • Growth Driver: The Rise In Long-Lasting And Communicable Diseases Fueling Market Growth Due To Increasing Transmission And Need For Advanced Immunotherapies • Market Trend: Innovative Personalized Cancer Vaccines Aim To Boost Immune Response And Improve Survival In High-Risk Melanoma • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under mRNA Therapeutics Market?

Messenger RNA (mRNA) therapeutics refers to a type of medical treatment that utilizes messenger RNA (mRNA) molecules to produce therapeutic proteins within the body. These therapeutics are used to prevent, treat, or cure diseases by directing cells to produce specific proteins that are needed for therapeutic effects. The main products of mRNA therapeutics are vaccines and drugs. Vaccines in the mRNA therapeutics category refer to pharmaceutical products that use messenger RNA to instruct cells to produce proteins that trigger an immune response against specific diseases. Which can be useful for various applications including infectious diseases, oncology, rare genetic diseases, respiratory diseases, and others, end users are hospitals and clinics, research organizations, and others.

What Is The mRNA Therapeutics Market Growth Forecast?

The mrna therapeutics market size is expected to see steady growth in the next few years. It will grow to $42.32 billion in 2030 at a compound annual growth rate (CAGR) of 3.3%. The growth in the forecast period can be attributed to rising demand for targeted and personalized therapies, expansion of mrna applications in oncology and rare diseases, growing biopharmaceutical investment in mrna pipelines, increasing number of mrna drugs entering clinical trials, strategic partnerships between biotech firms and research organizations. Major trends in the forecast period include expansion of mrna therapeutics beyond vaccines, growing focus on protein replacement therapies using mrna, rising clinical pipeline for non-vaccine mrna drugs, increasing investment in lipid nanoparticle delivery systems, acceleration of end-to-end mrna manufacturing capabilities.

Global mRNA Therapeutics Market Segmentation

1) By Product: Vaccines, Drugs 2) By Application: Infectious Diseases, Oncology, Rare Genetic Diseases, Respiratory Diseases, Other Applications 3) By End Use: Hospitals And Clinics, Research Organizations, Other End Uses Subsegments: 1) By Vaccines: Infectious Disease Vaccines, Cancer Vaccines, Other Therapeutic Vaccines 2) By Drugs: Oncology Drugs, Cardiovascular Drugs, Autoimmune Disease Drugs, Other mRNA-Based Drugs

What Is The Driver Of The mRNA Therapeutics Market?

The increasing prevalence of long-lasting and communicable diseases is expected to propel the growth of the mRNA therapeutics market going forward. Long-lasting and communicable diseases are illnesses that persist for extended periods and can spread between individuals, including conditions such as tuberculosis, HIV/AIDS, and hepatitis. The rise in these diseases is driven by factors such as increased global mobility and gaps in healthcare infrastructure, which contribute to greater transmission rates and hinder effective disease management. mRNA therapeutics support improved disease control by rapidly enabling the body to produce proteins that enhance immune responses, facilitating the accelerated development of targeted vaccines and treatments. For instance, in March 2024, according to the Centers for Disease Control and Prevention, a US-based government agency, the number of tuberculosis cases increased from 8,320 in 2022 to 9,615 in 2023, representing a rise of 1,295 cases. Therefore, the increasing prevalence of long-lasting and communicable diseases is driving the growth of the mRNA therapeutics industry.

Key Players In The Global mRNA Therapeutics Market

Major companies operating in the mrna therapeutics market are Pfizer Inc., Novartis AG, Sanofi AG, AstraZeneca plc, GlaxoSmithKline plc, Hoffmann-La Roche AG, Moderna Therapeutics Inc, BioNTech SE, Vertex Pharmaceuticals Incorporated, Catalent Inc, Alnylam Pharmaceuticals Inc, Sarepta Therapeutics Inc, Arcturus Therapeutics Holdings Inc, CureVac N.V, Ethris GMBH, eTheRNA immunotherapies NV, In-Cell-Art S.A.S., Nutcracker Therapeutics Inc, SCM LifeScience Co Ltd, Suzhou Abogen Biosciences Co Ltd, Tiba Biotech LLC, CSPC Pharmaceutical Group, CRISPR Therapeutics AG

Global mRNA Therapeutics Market Trends and Insights

Major companies operating in the mRNA therapeutics market are focusing on developing innovative solutions, such as personalized neoantigen vaccines, to enhance immune response and improve survival outcomes in cancer patients. Personalized neoantigen vaccines are cancer therapies designed for each patient, using unique tumor-specific mutations to stimulate the immune system to target and destroy cancer cells. For instance, in July 2023, Merck & Co., Inc., a US-based research-intensive biopharmaceutical company, partnered with Moderna Therapeutics, Inc., a US-based biotechnology company, to initiate a Phase 3 randomized clinical trial (V940-001) to evaluate mRNA-4157 (V940) in combination with KEYTRUDA® (pembrolizumab) as an adjuvant treatment for patients with resected high-risk (Stage IIB-IV) melanoma. This study follows positive results from the Phase 2b KEYNOTE-942/mRNA-4157-P201 trial, which showed a meaningful benefit of the combination over KEYTRUDA alone in reducing recurrence and distant metastasis risk. The Phase 3 trial aims to confirm these findings by assessing relapse-free survival and distant metastasis-free survival as primary and secondary endpoints, respectively.

What Are Latest Mergers And Acquisitions In The mRNA Therapeutics Market?

In June 2025, BioNTech SE, a Germany-based biotechnology company, acquired CureVac N.V. for an undisclosed amount. With the acquisition, BioNTech SE aims to strengthen the research, development, manufacturing, and commercialization of mRNA-based cancer immunotherapy candidates, marking a key milestone in its oncology strategy to advance innovative cancer treatments and establish new standards of care in the coming years. CureVac N.V. is a Germany-based company that develops mRNA-based therapies.

Regional Insights

North America was the largest region in the mRNA therapeutics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the mRNA Therapeutics Market?

The mRNA therapeutics market consists of revenues earned by entities by providing services such as vaccine development, protein replacement therapies, gene editing, monoclonal antibody production, and cancer treatment. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the mRNA Therapeutics Market Report 2026?

The mrna therapeutics market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the mrna therapeutics industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.